arrow
L

Lianhao Wang

c sinovac biotech, beijing, chinacontributionresources, supervision
H指数:5
被引数:58

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lot-to-lot consistency, immunogenicity, and safety of a 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy adults aged 40–65 years: A randomized, double-blind, controlled, phase IV clinical trial

批间一致性、免疫原性和安全性:一项在40~65岁健康成人中进行的23价肺炎球菌多糖疫苗(PPV23)的随机、双盲、对照IV期临床试验

2025-10-300
OAAI
Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

新型冠状病毒肺炎灭活疫苗的免疫原性和安全性 (CoronaVac®) 与灭活的肠病毒71型疫苗 (Inlive®): 第四阶段随机对照试验

2024-09-230
OAAI